Список основных многоцентровых исследований

4S — Scandinavian Simvastatin Survival Study

ACTION — A Coronary disease Trial Investigating Outcome with Nifedipine GITS

ASTEROID — A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound-Derived coronary atheroma burden

ATP — Angina Treatment Pattern

AVERT — Atorvastatin Versus Revascularisation Treatments

BEAUTIfFUL — MorBidity-mortality EvAlUtion of The If inhibitor — ivabradin in patients with CHD and leFt ventricULar disfunction

CAPRI Ε — Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events

CASS — Coronary Artery Surgery Study

COURAGE — Clinical Outcomes Utilizing Revascularization and Aggressive Guideline-driven drag Evaluation

EUROPA — European trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease

FIELD — Fenofibrate Intervention and Event Lovering in Diabetes

Framingham — Framingham Heart Study

GISSI-Prevenzione — Investigators Gruppo Italiano per lo Studio della

Sopravvivenza nell’Infarto mioeardie& — Prevenzione HOPE — Heart Outcomes Prevention Evaluation study Η PS — Heart Protection Study

INVEST — International Verapamil SR/ Trandolapril study

LIPID — Long-term Intervention with Pravastatin in Ischemic Disease

MDPIT — Multicenter Diltiazem Post-Infarction Trial PACIFIC — Prevention with A Combined Inhibitor and

Folic acid In Coronary heart disease

PEACE — Prevention of Events with Angiotensin- Converting Enzyme inhibition

QUIET — Quinapril Ischemic Event Trial

RWEL — RAndomised (double blind) study with the Sirolimus coated BX VElocity balloon expandable stent (CYPHER) in the treatment of patients with De Novo native coronary artery Lesions Randomized Study with The Sirolimus Eluting Velocity Balloon Expandable Stent

REVERSAL — Reversal of Atherosclerosis with Aggressive Lipid lowering

TIBBS — Total Ischemic Burden Bisoprolol Study TIBET — Total Ischaemic Burden European Trial

Основные лекарственные препараты для лечения стабильной стенокардии

Антитромбоцитарные препараты

Примечание: оригиналвный препарат выделен жирным шрифтом.